Most GLP‑1 prescriptions are missing the protocol that actually makes them work. Muscle loss, weight regain after stopping, side effect mismanagement — and no optimization support from your prescriber.
This training is educational only. Results vary. Not a substitute for your treating physician.
Most patients receive a prescription, a starting dose, and almost no clinical guidance. The result: side effects that could be avoided, muscle loss that shouldn’t happen, and no real plan for what comes next.
“I’ve lost weight, but my doctor never told me about muscle loss, protein targets, creatine, or what happens when I stop. I’m figuring this out on my own.”
You’re experiencing nausea, fatigue, or GI side effects — and your prescriber just told you to push through or drop your dose
You’re losing weight but worried about losing muscle — and nobody has told you how to prevent the 25–39% lean mass loss documented in STEP trial DXA data
You don’t know whether semaglutide, tirzepatide, or retatrutide is right for your specific metabolic situation
You’re concerned about weight regain after stopping — and the STEP 4 and SURMOUNT-4 withdrawal data is alarming you
Your baseline labs were never ordered — no fasting insulin, HOMA-IR, body composition, or thyroid panel before starting
You want physician-grade education, not influencer content — you need the actual clinical trial data so you can make informed decisions
GLP‑1 medications are among the most powerful metabolic tools in modern medicine. But the clinical trial data shows outcomes are dramatically different with vs. without the right optimization protocol.
STEP trial DXA data shows 25–39% of weight lost on GLP‑1 can be lean mass without a protocol. Four pillars prevent this: protein ≥1.2g/kg, creatine 5g/day, resistance training 3–4×/week, and HMB 3g/day if over 50.
Muscle PreservationSURMOUNT‑5 showed tirzepatide beat semaglutide head-to-head. TRIUMPH‑4 Phase 3 showed retatrutide at −28.7% — approaching bariatric surgical numbers. How to choose based on your metabolic profile.
Drug Selection Science80% of GLP‑1 side effects come from escalating too fast. Three clinical rules: tolerance phase is real (first 4 weeks are not therapeutic), never escalate while nauseated, inject at bedtime. Most prescribers don’t tell their patients any of these.
Titration ProtocolSUSTAIN‑6: 26% reduction in CV events. LEADER: 22% reduction in CV death. SELECT: 17,604 patients with no diabetes at baseline. The CV benefit appeared before weight loss — there is a direct cardiac mechanism that isn’t about the scale.
Cardiovascular DataBaseline Labs → Drug & Dose Selection → Titration Protocol → Muscle Preservation → Long-Term Strategy. The exact sequence and the exact clinical data behind each step — covered in full in this training.
Clinical Optimization ProtocolThis is physician-grade clinical education — the actual trial data, the actual protocols, and the clinical framework Dr. Baird uses with his own patients at Rejuv Medical Louisville. Whether you are a patient optimizing your own protocol or a clinician building your GLP‑1 prescribing framework, this masterclass was built for you.
You are a physician, NP, or clinician seeking a structured, evidence-based GLP‑1 prescribing and optimization framework
You are currently on semaglutide, tirzepatide, or considering starting a GLP‑1 medication and want physician-grade guidance
You want the actual Phase 3 trial data — SUSTAIN, SELECT, SURMOUNT, TRIUMPH — not social media summaries
You have obesity, type 2 diabetes, prediabetes, or metabolic syndrome and want to understand your full clinical picture
You are worried about muscle loss, weight regain after stopping, or long-term metabolic outcomes on GLP‑1 therapy
You want to understand retatrutide and the next wave of GLP‑1 agents before they reach mainstream prescribing
You want a quick fix without understanding the metabolic infrastructure needed for lasting results
You are not open to adjusting your protocol based on what the clinical trial data actually shows
You expect the medication alone to do all the work — without addressing nutrition, resistance training, or lab monitoring
You are looking for a replacement for your treating physician relationship
In 35 years of practicing medicine and treating over 20,000 patients, I have watched GLP‑1 medications go from niche diabetes tools to the most significant metabolic intervention in modern medicine. And I have watched most patients receive almost no clinical support for using them correctly.
I built this masterclass because physician-grade GLP‑1 education should not be gated behind a specialist referral. The trial data is clear, the protocols are proven, and every patient on these medications deserves to understand what they are actually taking — and how to use it to build lasting metabolic health, not just lose weight temporarily.
“GLP‑1 medications are genuinely extraordinary. But the way most patients use them — without a muscle preservation protocol, without baseline labs, without a titration plan — leaves most of the benefit on the table. In this free masterclass, I’m sharing the complete clinical framework I use with my own patients so you can finally use these medications the way the trial data says they should be used.”
A complete physician-led education in GLP‑1 pharmacology, trial evidence, and clinical optimization — no jargon shortcuts, no influencer summaries, no sales pitch disguised as content.
GLP‑1 receptors are expressed in the gut, pancreas, brain, heart, kidneys, and liver. Understanding the multi-organ mechanism explains why these drugs do far more than reduce appetite — and why they work differently in different metabolic subtypes.
Module 01SUSTAIN‑6, LEADER, SELECT (17,604 patients, no baseline diabetes), SURMOUNT‑5 (tirzepatide vs. semaglutide head-to-head), and TRIUMPH‑4 Phase 3 retatrutide. The actual numbers, the actual significance, and what they mean for your specific situation.
Module 02A dual GIP/GLP‑1 agonist outperforms a GLP‑1 alone — and a triple agonist outperforms both in Phase 3. How to select based on HbA1c, fasting insulin, HOMA-IR, cardiovascular risk, and cost. Drug comparison table included.
Module 03The tolerance phase is real: first 4 weeks are not therapeutic — they are adaptation. Three inviolable clinical rules: never escalate while symptomatic, inject at bedtime, stay at each dose for a minimum of 4 weeks. Complete titration ladders for all three agents.
Module 04STEP DXA data: without intervention, most weight lost includes significant lean mass. The four-pillar protocol: protein ≥1.2g/kg body weight, creatine monohydrate 5g/day, resistance training 3–4×/week, and HMB 3g/day for patients over 50.
Module 06STEP 4 and SURMOUNT‑4 withdrawal data: most patients regain significant weight after stopping. The metabolic infrastructure that must be built during treatment to change that outcome. Retatrutide, orforglipron, and the 2026–27 GLP‑1 pipeline.
Module 10Complete physician-led education in GLP‑1 pharmacology, clinical trial evidence, and optimization protocol — delivered in one session with no filler and no fluff.
Live + Automated · 24/7Ask your specific questions directly during scheduled live sessions and receive physician-level answers about your GLP‑1 protocol, labs, and metabolic situation.
Direct Physician AccessFree PDF for all registrants — the complete baseline lab checklist, titration ladder, muscle preservation protocol checklist, and what to ask your prescriber.
Free PDF · All RegistrantsCan’t attend live? A full replay link is sent automatically after your session and remains active for 48 hours — so you can watch on your schedule.
Auto-Sent After SessionThe complete evidence-based supplement stack: creatine monohydrate, HMB, magnesium glycinate, and more — with clinical rationale and Fullscript dispensary access at 20% off.
Included in TrainingA complete clinical education — not a disguised sales pitch. No purchase required to attend or to receive the patient quick-reference card. No spam. No pressure.
Private · ConfidentialVerified reviews from real patients · John Baird, MD, PLLC · New reviews appear automatically.
The program is the education, tools, and clinical guidance. Lab testing and supplements are separate — you control those costs directly through your own provider and Fullscript at 20% off.
Complete GLP‑1 clinical education. Self-directed. Full curriculum, tools, supplement protocol, and community access. No live calls.
Everything in Self-Study, plus monthly live group calls with Dr. Baird, lab review, and personal coaching from a certified GLP‑1 health coach.
Everything in Guided, plus direct physician access — Dr. Baird personally reviews your labs, interprets your results, and writes your individualized protocol.
Full refund within 7 days if no content has been accessed. After 7 days or content accessed: no refund. All sales are final after 30 days. Your investment in real clinical education is protected.
Sessions available 24/7 · 100% free · Private & confidential · Replay available 48 hours
DISCLAIMER: This masterclass is for educational purposes only. Dr. Baird is presenting as an educator — not as your treating physician. Nothing in this training constitutes medical advice or creates a physician-patient relationship. All clinical information should be discussed with your personal healthcare provider before making any changes to your medication, supplements, or health protocol. Results described are composite de-identified clinical cases — individual outcomes vary and are not guaranteed. Lab testing and supplements are additional costs not included in program pricing. Retatrutide is an investigational agent and is not FDA approved as of the date of this training.